Pfizer Inc. subsidiary Greenstone LLC recalled one lot of its Citalopram depression medicine and its prostate drug Finasteride because the wrong labels may have been put on the bottles, said the U.S. Food and Drug Administration.
Greenstone said in a recall notice that bottles of Citalopram, a generic drug with trade names including Celexa, may contain Finasteride, used to treat prostate problems and baldness in men. Finasteride’s trade names include Proscar, Propecia and several others.

Read the rest — Fear of Switched Labels Prompts Recall of Antidepressant, Prostate Drugs
The recall includes 100 count bottles of 10mg citalopram and 90 count bottles of 5mg finasteride. Both are generic, non-name-brand varieties (so you’re fine if you have Proscar; Propecia is not included in the recall).
The article does say — “Both have the lot number FI050058-A on the label.” So if you are taking 5mg finasteride, double check the lot number on the bottle.

While I’m not entirely familiar with medications transgender patients might take, consider this — most male to female transgender patients do not want male pattern baldness, so finasteride is a good choice to prevent that. Propecia is not a medication to make you transgendered. In other words, transgender people do not take Propecia to make them “more” transgendered.
To clarify, I was never paid by Merck. Anyone can post comments on forums, but this is bordering on slander.
I would say it is coincidence, mostly because nothing changes in the matter of days. And generic finasteride 5mg should be same everywhere, unless it is a counterfeit medication that is widely sold through the internet. There was just a segment on the 60 Minutes TV show about the